Genopole keeps you informed...


In the press

number of

The 2021 media results for Genopole and the biocluster comprised progressions of 36% for the number of articles and 66% for the number of mobilized supports. The published articles present Genopole as a place of biotech innovation and a supporter of project and business creation. Genopole is also identified as an actor in the development of the territory.

number of mobilized
In the press


Genopole is publishing a collection of pamphlets presenting its three strategic sectors. The first of them, published in 2021, focuses on innovative biotherapies and provides a panorama of the entire value chain present at the biocluster. It discusses Genopole’s targeted training offer and its academic laboratories, technological platforms and businesses covering the full scope of biotherapeutic innovation, from the discovery of novel gene and cell therapies through to the development of biomanufacturing and industrialization processes. The collection will be completed with two other pamphlets on the bioeconomy and computational genomics, Genopole’s two other strategic sectors.

Download the brochure